FDA Enforcement Class II Terminated

Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2

Recall: Z-1274-2021 · Reported March 24, 2021

Enforcement

Recall Number
Z-1274-2021
Event ID
87381
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Siemens Healthcare Diagnostics, Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
March 24, 2021
Initiation Date
February 8, 2021
Classification Date
March 18, 2021
Termination Date
February 7, 2025
Address
333 Coney St, N/A, East Walpole, MA, 02032-1516, United States

Description

Enzyme linked immunosorbent assay, for herpes simplex virus, hsv-2

Reason

Potential false positive HSV results. Siemens Healthcare Diagnostics, Inc. initiated a correction for ADVIA Centaur4P Herpes-2 lgG (HSV2) Onboard Stability and Calibration Frequency (Interval) Failures on the ADVIA Centaur XP System and ADVIA Centaur XPT System.

Code Info

***Updated as of 3/25/2021*** Lot #: B33255, B33269, B33413. UDI #: (01)00630414016726(10)B33255(17)20210625, (01)00630414016726(10)B33269(17)20210629, (01)00630414016726(10)B33413(17)20210819. Updated as of 3/25/2021

Distribution

Domestic: AL, CA, FL, IL, MD, NJ, NY, TN, TX. Foreign: Nepal, Chile, Georgia, Spain.

Quantity

390 kits total (Domestic 366 kits, Foreign 24 kits)